FOX 13's Allie Corey sat down with the chief of surgical oncology at TGH Institute and professor of surgery at USF Health as ...
Researchers at the University of Iowa found that adding high-dose IV vitamin C to chemotherapy helped increase survival in ...
A study published in the November issue of Redox Biology has found that adding intravenous, high-dose vitamin C to a ...
Patients with locally advanced pancreatic cancer demonstrated a two-month difference in survival with tumor-treating fields ...
Mark Spain, who was an evening anchor at Action News Jax from 2007 to 2014, revealed in a post on his professional Facebook ...
There's no routine screening test for pancreatic cancer, and symptoms can be mistaken for common illnesses.
Novocure said on Monday its experimental therapy extended the lives of patients with a form of advanced pancreatic cancer when combined with chemotherapy, achieving the primary goal in a late-stage ...
The FDA has granted accelerated approval to zenocutuzumab for treating patients with advanced pancreatic cancer or non-small ...
Novocure’s positive phase 3 results boost pancreatic cancer treatment prospects. Read why NVCR stock is worth watching with ...
Cancer researchers at Fox Chase Cancer Center see promise in personalized medicine to help crack the code on improving diagnosis and treatment options for pancreatic cancer.
NovoCure's TTFields therapy, combined with standard chemotherapy, improves overall survival in advanced pancreatic cancer.
Using tumor-treating fields alongside chemotherapy improved patient survival, Novocure said. Elsewhere, Cytokinetics got a ...